Immunic
IMUX | NASDAQ
$7.23
-$0.29 (-3.86%)
At close: Nov 16, 2026, 4:00 PM ET
$7.23
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.86%
(1D)No price chart data available for 1D timeframe.
Rating
37
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #605/1021 (Top 59%)
Key Statistics
Market Data
Market Cap $98.65M
1D Range
7.21 7.83
52W Range
5.10 16.90
Valuation (TTM)
PE -1.62
PB 0.94
EV/EBITDA 0.26
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $45.00
Cash Flow
FCF Yield -97.7%
SBC Adj. FCF Yield -124.5%
SBC Impact -27.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 46.6% |
42.3%
FCF 3Y | 5Y -11.5% |
-7.7%
Returns
ROA -94.0%
ROE -136.3%
ROIC -128.7%
Financial Health
Net Cash
$131.96M
Current Ratio 4.28
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditi...
Sector Healthcare
Industry Biotechnology
Employees 100
IPO Date Apr 17, 2014
Website imux.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$45.00
Upside
+522.41%
Buy (3)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove IMUX